These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 38339240)

  • 1. In Vitro Sensitivity of Neuroendocrine Neoplasms to an Armed Oncolytic Measles Vaccine Virus.
    Scheicher NV; Berchtold S; Beil J; Smirnow I; Schenk A; Lauer UM
    Cancers (Basel); 2024 Jan; 16(3):. PubMed ID: 38339240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulsed versus continuous application of the prodrug 5-fluorocytosine to enhance the oncolytic effectiveness of a measles vaccine virus armed with a suicide gene.
    Yurttas C; Berchtold S; Malek NP; Bitzer M; Lauer UM
    Hum Gene Ther Clin Dev; 2014 Jun; 25(2):85-96. PubMed ID: 24933569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel armed oncolytic measles vaccine virus for the treatment of cholangiocarcinoma.
    Lange S; Lampe J; Bossow S; Zimmermann M; Neubert W; Bitzer M; Lauer UM
    Hum Gene Ther; 2013 May; 24(5):554-64. PubMed ID: 23550539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced killing of ovarian carcinoma using oncolytic measles vaccine virus armed with a yeast cytosine deaminase and uracil phosphoribosyltransferase.
    Hartkopf AD; Bossow S; Lampe J; Zimmermann M; Taran FA; Wallwiener D; Fehm T; Bitzer M; Lauer UM
    Gynecol Oncol; 2013 Aug; 130(2):362-8. PubMed ID: 23676551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An armed oncolytic measles vaccine virus eliminates human hepatoma cells independently of apoptosis.
    Lampe J; Bossow S; Weiland T; Smirnow I; Lehmann R; Neubert W; Bitzer M; Lauer UM
    Gene Ther; 2013 Nov; 20(11):1033-41. PubMed ID: 23719065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary resistance phenomena to oncolytic measles vaccine viruses.
    Noll M; Berchtold S; Lampe J; Malek NP; Bitzer M; Lauer UM
    Int J Oncol; 2013 Jul; 43(1):103-12. PubMed ID: 23612727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing and Overcoming Resistance Phenomena against a Genetically Modified Vaccinia Virus in Selected Cancer Cell Lines.
    Berchtold S; Beil J; Raff C; Smirnow I; Schell M; D'Alvise J; Gross S; Lauer UM
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33076270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Three-Dimensional Organoid Model of Primary Breast Cancer to Investigate the Effects of Oncolytic Virotherapy.
    Carter ME; Hartkopf AD; Wagner A; Volmer LL; Brucker SY; Berchtold S; Lauer UM; Koch A
    Front Mol Biosci; 2022; 9():826302. PubMed ID: 35223990
    [No Abstract]   [Full Text] [Related]  

  • 9. Innate immune defense defines susceptibility of sarcoma cells to measles vaccine virus-based oncolysis.
    Berchtold S; Lampe J; Weiland T; Smirnow I; Schleicher S; Handgretinger R; Kopp HG; Reiser J; Stubenrauch F; Mayer N; Malek NP; Bitzer M; Lauer UM
    J Virol; 2013 Mar; 87(6):3484-501. PubMed ID: 23302892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncolytic vaccinia virus GLV-1h68 exhibits profound antitumoral activities in cell lines originating from neuroendocrine neoplasms.
    Kloker LD; Berchtold S; Smirnow I; Beil J; Krieg A; Sipos B; Lauer UM
    BMC Cancer; 2020 Jul; 20(1):628. PubMed ID: 32631270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MeV-Stealth: A CD46-specific oncolytic measles virus resistant to neutralization by measles-immune human serum.
    Muñoz-Alía MÁ; Nace RA; Tischer A; Zhang L; Bah ES; Auton M; Russell SJ
    PLoS Pathog; 2021 Feb; 17(2):e1009283. PubMed ID: 33534834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suicide gene‑armed measles vaccine virus for the treatment of AML.
    Maurer S; Salih HR; Smirnow I; Lauer UM; Berchtold S
    Int J Oncol; 2019 Aug; 55(2):347-358. PubMed ID: 31268165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Starvation-Induced Differential Virotherapy Using an Oncolytic Measles Vaccine Virus.
    Scheubeck G; Berchtold S; Smirnow I; Schenk A; Beil J; Lauer UM
    Viruses; 2019 Jul; 11(7):. PubMed ID: 31284426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemovirotherapy for pancreatic cancer: Gemcitabine plus oncolytic measles vaccine virus.
    May V; Berchtold S; Berger A; Venturelli S; Burkard M; Leischner C; Malek NP; Lauer UM
    Oncol Lett; 2019 Nov; 18(5):5534-5542. PubMed ID: 31612061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemovirotherapy of malignant melanoma with a targeted and armed oncolytic measles virus.
    Kaufmann JK; Bossow S; Grossardt C; Sawall S; Kupsch J; Erbs P; Hassel JC; von Kalle C; Enk AH; Nettelbeck DM; Ungerechts G
    J Invest Dermatol; 2013 Apr; 133(4):1034-42. PubMed ID: 23223133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Oncolytic Herpes Simplex Virus Talimogene Laherparepvec Shows Promising Efficacy in Neuroendocrine Cancer Cell Lines.
    Kloker LD; Berchtold S; Smirnow I; Schaller M; Fehrenbacher B; Krieg A; Sipos B; Lauer UM
    Neuroendocrinology; 2019; 109(4):346-361. PubMed ID: 31280274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-sensitive oncolytic measles virus for chemovirotherapy of pancreatic cancer.
    Singh HM; Leber MF; Bossow S; Engeland CE; Dessila J; Grossardt C; Zaoui K; Bell JC; Jäger D; von Kalle C; Ungerechts G
    Mol Ther Oncolytics; 2021 Jun; 21():340-355. PubMed ID: 34141871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human precision-cut liver tumor slices as a tumor patient-individual predictive test system for oncolytic measles vaccine viruses.
    Zimmermann M; Armeanu S; Smirnow I; Kupka S; Wagner S; Wehrmann M; Rots MG; Groothuis GM; Weiss TS; Königsrainer A; Gregor M; Bitzer M; Lauer UM
    Int J Oncol; 2009 May; 34(5):1247-56. PubMed ID: 19360338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of measles virus oncolytic immunotherapy.
    Pidelaserra-Martí G; Engeland CE
    Cytokine Growth Factor Rev; 2020 Dec; 56():28-38. PubMed ID: 32660751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-Tumor Effects of MAPK-Dependent Tumor-Selective Oncolytic Vaccinia Virus Armed with CD/UPRT against Pancreatic Ductal Adenocarcinoma in Mice.
    Kurosaki H; Nakatake M; Sakamoto T; Kuwano N; Yamane M; Ishii K; Fujiwara Y; Nakamura T
    Cells; 2021 Apr; 10(5):. PubMed ID: 33922406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.